Micrometastases in bone marrow in patients with primary breast cancer: Evaluation as an early predictor of bone metastases

British Medical Journal (Clinical research ed.)

Volumn 295, Issue 6606, 1987, Pages 1093-1096

  Mansi, Janine L ^a   Berger, Uta ^a   Coombes, R Charles ^a   Mcdonnell, Tracy ^a   Easton, Douglas ^a   Redding, W Howard ^b   Gazet, Jean Claude ^c   Mckinna, Alan ^d   Powles, Trevor J ^e  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b EPSOM GENERAL HOSPITAL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD AND HEMOPOIETIC SYSTEM; BONE; BONE MARROW METASTASIS; BONE METASTASIS; BREAST; BREAST CANCER; CYTOLOGY; DIAGNOSIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROMETASTASIS;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; BONE MARROW EXAMINATION; BONE NEOPLASMS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMAN; MIDDLE AGE; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0023626357     PISSN: 02670623     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.295.6606.1093     Document Type: Article

References (22)

1. Coombes RC, Powles T., Abbott M, et al. Physical tests for distant metastases in patients with breast cancer. J R SocMed 1980;73:617–23.
2. Coombes RC, Dearnaley DP, Redding WH, et al. Micrometastases in breast cancer. In: Peeters H, ed. Protides of the biological fluids. Vol 31. Oxford: Pergamon, 1983:317–23.
3. Jaffe HL. Tumors metastatic to the skeleton. In: Jaffe HL, ed. Tumors and tumorous conditions of the bones and joints. Philadelphia: Lea and Febiger, 1968:589–618.
4. Ridell B, Landys K. Incidence and histopathology of metastses of mammary carcinoma in biopsies from the posterior iliac crest. Cancer 1979;44:1782–8.
5. Ingle JN, Tormey DC, Tan HK. The bone marrow examination in breast cancer. Cancer 1978;41:670–4.
6. Dearnaley DP, Sloane JP, Ormerod MG, et al. Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer 1981;44:85–90.
7. Dearnaley DP, Ormerod MG, Sloane JP, et al. Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer. J R Soc Med 1983;76:359–64.
8. Bettelheim R, Neville AM. Lymphatic and vascular channel involvement within infiltrative breast carcinoma as a guide to prognosis at the time of primary surgical treatment. Lancet 1981; ii:631.
9. Bonadonna G, Rossi A, Valagussa P, Banfi A, Veronesi U. The CMF program for operable breast cancer with positive axillary nodes. Cancer 1977;39:2904.
10. Heyderman E, Steele K, Ormerod MG. A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue. J Clin Pathol 1979;32:35–9.
11. Ormerod MG, Steele K, Westwood JH, Mazzini MN. Epithelial membrane antigen: partial purification, assay and properties. Br J Cancer 1983;48:533–41.
12. Delsol G, Gatter KC, Stein H, et al. Human lymphoid cells express epithelial membrane antigen: implication for diagnosis of human neoplasms. Lancet 1984;ii: 1124–8.
13. Sloane JP, Dearnaley DP, Ormerod MG. Epithelial membrane antigen and lymphoid cells. Lancet 1985; i: 109–10.
14. Hayward JL, Carbone PP, Heuson J.C., et al. Assessment of response to therapy in advanced breast cancer. Cancer 1977;39:1289–94.
15. Coombes R.C., Powles T.J., Gazet J.C., et al. Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet 1980;i:296–8.
16. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1–39.
17. Redding WH, Coombes RC, Monaghan P, et al. Detection of micrometastases in patients with primary breast cancer. Lancet 1983;ii: 1271–4.
18. Berger U, Bettelheim R, Mansi JL, Easton D, Coombes RC, Neville AM. The relationship between micrometastases in the bone marrow, histopathologic features of the primary tumor in breast cancer and prognosis. Am J Clin Pathol (in press).
19. Nime FA, Rosen PP, Thaler HT, Ashikari R, Urban JA. Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma. Am J Surg Pathol 1977;i:25–30.
20. Bettelheim R, Penman HG, Thornton-Jones H, Neville AM. Prognostic significance of peritumoral vascular invasion in breast cancer. Br J Cancer 1984;50:771–7.
21. Davis BW, Gelber R, Goldhirsch A, et al. (for the Ludwig Breast Cancer Study Group). Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis. Hum Pathol 1985;16:1212–8.
22. Coombes RC, Buckman R, Forrester JA, et al. In vitro and in vivo effects of a monoclonal antibody-toxin conjugate for use in autologous bone marrow transplantation for patients with breast cancer. Cancer Res 1986;46:4217–20.